Ongoing large outbreaks in states including South Carolina, Utah, and Texas continue to drive the U.S. measles case count, which reached 1,842 confirmed infections as of May 7 according to CDC surveillance data. With 93 percent of cases linked to outbreaks and 92 percent occurring among unvaccinated or unknown-status individuals, transmission remains elevated in under-immunized communities. The virus’s high contagiousness, characterized by a basic reproduction number of 12–18, sustains spread through respiratory droplets, particularly as summer travel increases importations. CDC weekly updates on case counts, hospitalization rates, and new jurisdictions reporting infections represent the key near-term data releases that could shift market-implied odds before the May 31 resolution.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · ОбновленоMeasles cases in U.S. by May 31?
Measles cases in U.S. by May 31?
$69,252 Объем
31 мая 2026 г.
1900
99%
1925
97%
1950
68%
2000
12%
2200
2%
2400
1%
$69,252 Объем
1900
$29,844 Объем
99%
1925
$5,375 Объем
97%
1950
$11,830 Объем
68%
2000
$13,823 Объем
12%
2200
$2,644 Объем
2%
2400
$955 Объем
1%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing large outbreaks in states including South Carolina, Utah, and Texas continue to drive the U.S. measles case count, which reached 1,842 confirmed infections as of May 7 according to CDC surveillance data. With 93 percent of cases linked to outbreaks and 92 percent occurring among unvaccinated or unknown-status individuals, transmission remains elevated in under-immunized communities. The virus’s high contagiousness, characterized by a basic reproduction number of 12–18, sustains spread through respiratory droplets, particularly as summer travel increases importations. CDC weekly updates on case counts, hospitalization rates, and new jurisdictions reporting infections represent the key near-term data releases that could shift market-implied odds before the May 31 resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Открытие рынка: Apr 28, 2026, 6:09 PM ET
Объем
$69,252Дата окончания
31 мая 2026 г.Открытие рынка
Apr 28, 2026, 6:09 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing large outbreaks in states including South Carolina, Utah, and Texas continue to drive the U.S. measles case count, which reached 1,842 confirmed infections as of May 7 according to CDC surveillance data. With 93 percent of cases linked to outbreaks and 92 percent occurring among unvaccinated or unknown-status individuals, transmission remains elevated in under-immunized communities. The virus’s high contagiousness, characterized by a basic reproduction number of 12–18, sustains spread through respiratory droplets, particularly as summer travel increases importations. CDC weekly updates on case counts, hospitalization rates, and new jurisdictions reporting infections represent the key near-term data releases that could shift market-implied odds before the May 31 resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Объем
$69,252Дата окончания
31 мая 2026 г.Открытие рынка
Apr 28, 2026, 6:09 PM ETResolver
0x65070BE91...Ongoing large outbreaks in states including South Carolina, Utah, and Texas continue to drive the U.S. measles case count, which reached 1,842 confirmed infections as of May 7 according to CDC surveillance data. With 93 percent of cases linked to outbreaks and 92 percent occurring among unvaccinated or unknown-status individuals, transmission remains elevated in under-immunized communities. The virus’s high contagiousness, characterized by a basic reproduction number of 12–18, sustains spread through respiratory droplets, particularly as summer travel increases importations. CDC weekly updates on case counts, hospitalization rates, and new jurisdictions reporting infections represent the key near-term data releases that could shift market-implied odds before the May 31 resolution.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено
Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы